Application 090849
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXALIPLATIN | OXALIPLATIN | INJECTABLE;INTRAVENOUS | 50MG/VIAL | No | No |
| 002 | OXALIPLATIN | OXALIPLATIN | INJECTABLE;INTRAVENOUS | 100MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090849-001 | OXALIPLATIN | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | ||
| A090849-002 | OXALIPLATIN | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090849-001 | OXALIPLATIN | 50MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090849-002 | OXALIPLATIN | 100MG/VIAL | INJECTABLE / INTRAVENOUS | 2011-04-28 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxaliplatin | OXALIPLATIN | Gland Pharma Limited | a6f89dc3-a594-4b5b-8728-272e20c1ecb5 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Hospira, Inc. | e51a62ba-d163-4c57-835c-8c86cf097e40 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| oxaliplatin | OXALIPLATIN | Shandong New Time Pharmaceutical Co., Ltd. | 1ac38523-480b-4c0f-97a1-7dfa1432923c | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | NorthStar Rx LLC | f299b2d2-86ed-4fb8-822e-65455a0bb75a | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Northstar Rx LLC | 7dc8dfb1-dec8-43b3-b2ea-05eac054b2c6 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Camber Pharmaceuticals, Inc. | b0799e39-7b1e-430a-b159-062b39521001 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| oxaliplatin | OXALIPLATIN | Sagent Pharmaceuticals | 29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Mylan Institutional LLC | da0e8523-609a-4326-96b1-d7de78662d91 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | BluePoint Laboratories | b6083405-9b45-4d2c-e053-2995a90ad9ef | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Qilu Pharmaceutical Co., Ltd. | 33d4f4b4-bb4e-46af-9e89-df20154436d0 | 2024-11-14 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 11377169-7986-45b1-8298-6f0533efa3c3 | 2024-10-03 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | ee2e0da9-5ae7-405b-8dd1-635be72bc439 | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Apotex Corp. | ee5a5a1d-63f6-4d5a-901b-65be45ec6610 | 2024-08-04 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Apotex Corp. | bb180ec5-1f75-43c1-9f63-c0657af2ca5f | 2024-08-04 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Eugia US LLC | 1bb4febd-0ed4-48c9-ba2a-e22183a2143f | 2024-07-02 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 7e38318e-c569-4ad4-8f10-a235f30444d1 | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Meitheal Pharmaceuticals Inc. | 873fa936-157a-4f85-bc70-5df31d71d122 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| oxaliplatin | OXALIPLATIN | Accord Healthcare Inc. | 4b805925-beb1-2bac-e054-00144ff88e88 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | FOSUN PHARMA USA INC. | fad0f147-6595-4412-87a7-2afca0192a96 | 2023-10-09 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Sandoz Inc | 86f6c19d-30d1-42e3-8d46-5e3f45776e85 | 2023-07-25 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 22715 | ORIG | 2013-04-10 |